Skip to content

Functional Neurological Disorders in Patients Admitted in Stroke Units

Functional Neurological Disorders in Patients Admitted in Stroke Units: Clinical Profile et and 6 Months Follow-up

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04662372
Acronym
NEUROFON
Enrollment
40
Registered
2020-12-10
Start date
2021-03-05
Completion date
2025-10-31
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Neurological Disorders

Brief summary

Functional neurological disorders are an important subgroup of patients with stroke mimics admitted to stroke unit.Their clinical profile and outcome are poorly known. The goal of this study is to describe the cognitive and behavioral profile of stroke mimics patients, without evidence of neurological disease.

Interventions

description of the cognitive and behavioral profile of stroke mimics patients, without evidence of neurological disease.

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years old * Patients admitted in stroke unit for a neurological deficit, without evidence of neurovascular or othe neurological disease. * NIHSS ≥ 1 at time of admission * Informed and consent patient to study * Health insured

Exclusion criteria

* Patient receiving legal protection * Pregnant or breastfeeding woman

Design outcomes

Primary

MeasureTime frameDescription
Patient characteristics3 monthsCognitive/behavioural characteristics of patients assessed for stroke using the National Institute of Health Stroke Score ranging from 0 to 42 (0: no stroke; 1-4: minor stroke; 5-15: moderate stroke; moderate to severe stroke; 21-42: severe stroke)

Secondary

MeasureTime frameDescription
symptoms of patients3 and 6 monthsDescription of symptoms at 3 and 6 months after transition in stroke unit

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026